Item 7.01. Regulation FD Disclosure
On January 23, 2023, Viemed Healthcare, Inc. (the “Company”) issued a press
release announcing the ruling of a U.S. Department of Health and Human Services
Administrative Law Judge (“ALJ”) with respect to the appeal of claims related to
findings from the U.S. Department of Health and Human Services Office of
Inspector General (“OIG”). The ALJ’s Decision overturned all remaining disputed
claims. As a result, Medicare Administrative Contractors returned 100% of the
previously remitted funds to Viemed. The press release is attached hereto as
Exhibit 99.1 and is incorporated herein by reference.
In accordance with General Instruction B.2 of Form 8-K, the foregoing
information, including Exhibit 99.1, shall not be deemed “filed” for the
purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), or otherwise subject to the liabilities of that section, nor
shall such information and Exhibit 99.1 be deemed incorporated by reference in
any filing under the Securities Act of 1933, as amended, or the Exchange Act,
except as shall be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
Exhibit
Number Description
99.1 Press Release dated January 23 , 2023
104 Cover Page Interactive Data File, formatted in Inline XBRL and included as
Exhibit 101
——————————————————————————–
© Edgar Online, source Glimpses
postbrexitcompliance.com 